We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.46B
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+4.16%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
AUM
$5.46B
AUM Growth
+$264M
Cap. Flow
+$147M
Cap. Flow %
2.69%
Top 10 Hldgs %
33.99%
Holding
157
New
31
Increased
42
Reduced
55
Closed
27

Top Buys

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$90.4M
2
QRVO icon
Qorvo
QRVO
+$75.2M
3
META icon
Meta Platforms (Facebook)
META
+$52.4M
4
NVDA icon
NVIDIA
NVDA
+$45.8M
5
COF icon
Capital One
COF
+$42.3M

Top Sells

Rank Stock Value
1
WDAY icon
Workday
WDAY
+$59M
2
MSFT icon
Microsoft
MSFT
+$55.4M
3
AMZN icon
Amazon
AMZN
+$50.3M
4
MRK icon
Merck
MRK
+$40.2M
5
ORCL icon
Oracle
ORCL
+$31.2M

Sector Composition

Rank Sector Weight
1 Utilities 27.87%
2 Technology 14.3%
3 Healthcare 11.52%
4 Consumer Discretionary 9.78%
5 Energy 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
126
Tango Therapeutics
TNGX
$3.94B
$32.4K ﹤0.01%
1,037
-585
-36% -$14.5K
ANL
127
Adlai Nortye Group ADS
ANL
$890M
$18.9K ﹤0.01%
1,642
-409
-20% -$4.98K
RLMD icon
128
Relmada Therapeutics
RLMD
$462M
$16.7K ﹤0.01%
2,414
-621
-20% -$4.34K
ATAI icon
129
AtaiBeckley Inc
ATAI
$2.7B
$9.74K ﹤0.01%
1,849
-5,680
-75% -$23.9K
SQM icon
130
Sociedad Química y Minera de Chile
SQM
$22.5B
$8.81K ﹤0.01%
119
-63
-35% -$5.28K
ALC icon
131
Alcon
ALC
$34.8B
-26,559
Closed -$1.96M
AZO icon
132
AutoZone
AZO
$48.4B
-640
Closed -$2.16M
BSX icon
133
Boston Scientific
BSX
$67.9B
-1,128
Closed -$70.8K
CABA icon
134
Cabaletta Bio
CABA
$529M
-5,616
Closed -$15.1K
CLPR
135
Clipper Realty
CLPR
$53.6M
-125,668
Closed -$380K
COLD icon
136
Americold
COLD
$4.29B
-1,159,803
Closed -$13.3M
DXCM icon
137
DexCom
DXCM
$34.3B
-554
Closed -$34.8K
GILD icon
138
Gilead Sciences
GILD
$181B
-557
Closed -$77.6K
IDYA icon
139
IDEAYA Biosciences
IDYA
$3.87B
-917
Closed -$30.6K
IRON icon
140
Disc Medicine
IRON
$3.07B
-476
Closed -$30.4K
IRTC icon
141
iRhythm Holdings
IRTC
$3.96B
-655
Closed -$77.3K
KWEB icon
142
CALL
KraneShares CSI China Internet ETF
KWEB
$5.2B
-2,206
Closed -$48.5K
LXU icon
143
LSB Industries
LXU
$748M
-101,927
Closed -$1.52M
LZ icon
144
LegalZoom.com
LZ
$1.05B
-80,268
Closed -$455K
NUVL
145
DELISTED
Nuvalent
NUVL
-275
Closed -$28.2K
ORCL icon
146
Oracle
ORCL
$435B
-212,117
Closed -$31.2M
ORIC icon
147
Oric Pharmaceuticals
ORIC
$1.37B
-1,278
Closed -$16.2K
OTIS icon
148
Otis Worldwide
OTIS
$27.3B
-61,687
Closed -$4.75M
REGN icon
149
Regeneron Pharmaceuticals
REGN
$81.8B
-97
Closed -$74.9K
STNE icon
150
StoneCo
STNE
$2.24B
-45,575
Closed -$644K

Similar funds

Antipodes Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Antipodes Partners held 157 positions worth $5.46B, up 5.1% from $5.19B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Antipodes Partners's Q2 2026 filing shows 31 new, 42 increased, 55 reduced and 27 closed positions. Its largest new stake was Booking.com: 530,062 shares worth $94.2M. The largest sale was Workday, an estimated $59M.

By sector, the portfolio is most concentrated in Utilities at 28% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

  • Antipodes Partners's largest Q2 2026 buy was Booking.com: 530,062 shares worth $94.2M.
  • Antipodes Partners added most to Meta Platforms (Facebook) in Q2 2026, an estimated $52.4M increase.
  • Antipodes Partners's biggest Q2 2026 reduction was Workday, cutting an estimated $59M.
  • Antipodes Partners fully exited Oracle in Q2 2026, selling an estimated $31.2M.
  • Antipodes Partners's ten largest holdings make up 34% of its $5.46B portfolio in Q2 2026.
  • Antipodes Partners opened 31 new positions and closed 27 in Q2 2026.
  • Antipodes Partners's portfolio value rose 5.1% quarter-over-quarter to $5.46B.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.